Mountain Pacific Investment Advisers Inc Amgen Inc Transaction History

Mountain Pacific Investment Advisers Inc

$1.32 Billion
Q2 2024

A detailed history of Mountain Pacific Investment Advisers Inc transactions in Amgen Inc stock. As of the latest transaction made, Mountain Pacific Investment Advisers Inc holds 5,244 shares of AMGN stock, worth $1.66 Million. This represents 0.12% of its overall portfolio holdings.

Number of Shares

5,244

Previous 5,404 2.96%

Holding current value

$1.66 Million

Previous $1.54 Million 6.64%

% of portfolio

0.12%

Previous 0.09%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 10, 2024	SELL	$262.75 - $319.31 $42,040 - $51,089	-160 Reduced 2.96%	5,244 $1.64 Million
Q1 2024 Apr 11, 2024	SELL	$268.87 - $324.56 $16,132 - $19,473	-60 Reduced 1.1%	5,404 $1.54 Million
Q3 2023 Oct 20, 2023	BUY	$218.65 - $271.46 $3,061 - $3,800	14 Added 0.26%	5,464 $1.47 Million
Q2 2023 Jul 26, 2023	SELL	$214.27 - $253.37 $3,856 - $4,560	-18 Reduced 0.33%	5,450 $1.21 Million
Q1 2023 May 23, 2023	SELL	$225.79 - $275.2 $11,289 - $13,760	-50 Reduced 0.91%	5,468 $1.32 Million
Q3 2022 Oct 13, 2022	SELL	$224.46 - $253.15 $4,489 - $5,063	-20 Reduced 0.36%	5,518 $1.24 Million
Q1 2022 Apr 19, 2022	SELL	$219.27 - $242.57 $4,166 - $4,608	-19 Reduced 0.34%	5,538 $1.34 Million
Q4 2021 Jan 19, 2022	SELL	$198.88 - $227.6 $74,580 - $85,350	-375 Reduced 6.32%	5,557 $1.25 Million
Q3 2021 Oct 25, 2021	SELL	$212.27 - $248.7 $15,707 - $18,403	-74 Reduced 1.23%	5,932 $1.26 Million
Q2 2021 Aug 16, 2021	SELL	$233.58 - $259.14 $93,432 - $103,656	-400 Reduced 6.24%	6,006 $1.46 Million
Q4 2020 Jan 21, 2021	BUY	$216.38 - $257.67 $21,638 - $25,767	100 Added 1.59%	6,406 $1.47 Million
Q3 2020 Oct 13, 2020	SELL	$234.65 - $260.95 $132,577 - $147,436	-565 Reduced 8.22%	6,306 $1.6 Million
Q2 2020 Jul 09, 2020	BUY	$197.81 - $242.74 $69,035 - $84,716	349 Added 5.35%	6,871 $1.62 Million
Q1 2020 Apr 08, 2020	BUY	$182.24 - $241.7 $519,566 - $689,086	2,851 Added 77.66%	6,522 $1.32 Million
Q2 2019 Jul 23, 2019	BUY	$166.7 - $195.41 $110,021 - $128,970	660 Added 21.92%	3,671 $676,000
Q1 2018 Apr 30, 2018	BUY	$169.43 - $198.0 $12,198 - $14,256	72 Added 2.45%	3,011 $513,000
Q4 2017 Jan 23, 2018	BUY	$168.79 - $188.59 $26,837 - $29,985	159 Added 5.72%	2,939 $511,000
Q3 2017 Oct 20, 2017	BUY	$167.29 - $191.0 $465,066 - $530,980	2,780	2,780 $518,000

Others Institutions Holding AMGN

# of Institutions

3,058

Shares Held

409M

Call Options Held

7.19M

Put Options Held

6.3M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $170B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mountain Pacific Investment Advisers Inc, based on Form 13F filings with the SEC.

News

Stay updated on Mountain Pacific Investment Advisers Inc with notifications on news.

Account

Mountain Pacific Investment Advisers Inc Amgen Inc Transaction History